Literature DB >> 35349318

Federal and State Regulatory Changes to Methadone Take-Home Doses: Impact of Sociostructural Factors.

Janan P Wyatt1, Leslie W Suen1, William H Coe1, Zoe M Adams1, Mona Gandhi1, Hannah M Batchelor1, Stacy Castellanos1, Neena Joshi1, Shannon Satterwhite1, Rafael Pérez-Rodríguez1, Esther Rodríguez-Guerra1, Carmen E Albizu-Garcia1, Kelly R Knight1, Ayana Jordan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35349318      PMCID： PMC8965186          DOI： 10.2105/AJPH.2022.306806

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  6 in total

1.  Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care.

Authors:  Sarah E Wakeman; Josiah D Rich
Journal:  J Addict Dis       Date:  2015

2.  Private Coverage of Methadone in Outpatient Treatment Programs.

Authors:  Daniel Polsky; Samantha Arsenault; Francisca Azocar
Journal:  Psychiatr Serv       Date:  2019-12-11       Impact factor: 3.084

3.  Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.

Authors:  Sarah Brothers; Adam Viera; Robert Heimer
Journal:  J Subst Abuse Treat       Date:  2021-04-29

4.  Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19.

Authors:  Mary C Figgatt; Zach Salazar; Elizabeth Day; Louise Vincent; Nabarun Dasgupta
Journal:  J Subst Abuse Treat       Date:  2021-01-08

5.  Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms.

Authors:  Peter C Treitler; Cadence F Bowden; James Lloyd; Michael Enich; Amesika N Nyaku; Stephen Crystal
Journal:  J Subst Abuse Treat       Date:  2021-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.